74
Participants
Start Date
November 30, 2012
Primary Completion Date
January 31, 2015
Study Completion Date
March 31, 2015
antazoline
Patients assigned to antazoline group will be administered antazoline in boluses of 50mg diluted to 10cm3 every 5 minutes up to cumulative dose of 250mg or conversion of AF to SN. Drug administration will also be stopped in case of serious adverse event or conversion of AF to different supraventricular arrhythmia. BP will be measured before every injection.
0.9% saline
Patients assigned to control group will be administered 0.9% saline in boluses of 10cm3 every 5 minutes up to cumulative volume of 50cm3, conversion of AF to SN or in case of serious adverse event or conversion of AF to different supraventricular arrhythmia. BP will be measured before every injection.
Institute of Cardiology, II Dept. of Coronary Heart Disease, Warsaw
National Institute of Cardiology, Warsaw, Poland
OTHER